TLDR
- UNH beat Q1 earnings at $7.23 per share and raised its full-year adjusted EPS outlook to above $18.25
- CMS finalized a 2.48% Medicare Advantage rate increase for 2027, up from the 0.09% initially proposed
- UnitedHealth is investing $1.5 billion in AI in 2026, with tools like Optum Real cutting manual contact costs by up to 76%
- The company is exiting international markets, including the UK and South America, to refocus on the U.S.
- UNH stock was up over 3.5% on Tuesday, trading around $368, with 23 analysts setting an average price target of $384.59
UnitedHealth Group had a rough 18 months. Regulatory pressure, rising healthcare costs, and margin compression sent the stock down hard from its 2024 highs. But Q1 2026 is starting to look like a turning point.
UnitedHealth Group Incorporated, UNH
The company reported first-quarter earnings of $7.23 per share, beating expectations. Management followed that up by raising its full-year adjusted earnings outlook to more than $18.25 per share.
The stock responded. UNH gained more than 3.5% on Tuesday, trading around $368, even as the S&P 500 fell 0.64% and the Nasdaq dropped 1.22%.
One of the clearest tailwinds came from Washington. The Centers for Medicare & Medicaid Services finalized a 2.48% Medicare Advantage rate increase for 2027. That’s a big jump from the 0.09% increase proposed back in January.
The CMS now projects around $13 billion in additional payments to Medicare Advantage plans in 2027, compared to just $700 million projected earlier. For UnitedHealth, that means more room to price MA policies in line with actual healthcare costs.
AI Spending Starting to Show Results
UnitedHealth is putting $1.5 billion into AI investments in 2026. The first major product out of that effort is Optum Real, which automates parts of the managed care process including claim evaluation and coverage validation.
Management says Optum Real can cut manual contact costs by up to 76%. That’s a real number, and it matters for a business operating at scale.
Optum Rx also reported a 25% drop in call center volume after rolling out automated customer support. These aren’t small wins.
There’s a short-term cost to all this. The operating cost ratio climbed to 13.8% in Q1, up from 12.4% a year ago. That’s the price of building the infrastructure. The payoff is expected to come in future margins.
Exiting International Markets
UnitedHealth sold Optum UK in early March 2026 and is in the process of exiting its remaining South American businesses. Management confirmed on the Q1 call that the company is pulling back to its core U.S. healthcare operations.
International segments ran at lower margins and faced more regulatory friction. Getting out frees up capital and removes drag on overall profitability.
The company also announced the resumption of its share repurchase program in Q2, an early sign that freed-up capital will flow back to investors.
UNH now trades at roughly 19x forward earnings. The average price target from 23 Wall Street analysts sits at $384.59, implying about 4.86% upside from current levels.
The stock is still down 12.24% over the past 12 months, and the RSI hit 82.37 on Tuesday, suggesting some near-term heat in the move. Key resistance sits at $376, with support at $351.
đ¨ Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. Weâre also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
